|
|
|
|
|
|
|
|
|
|
Super Quote | Detail Quote | Interactive Chart | Transaction | Related News | Related Securities | Company Information | Dividend Records | Short Sell
09887 LEADS BIOLABS-B
Nominal 
66.900 -2.850 (-4.086%) | 2025/06 - Interim RMB(K¥) | 2024/12 RMB(K¥) | 2023/12 RMB(K¥) | |
| Net Cash from / (used in) Operating Activities | -- | (118,816) | (192,685) |
| Net Cash from / (used in) Investing Activities | -- | (67,302) | 135,492 |
| Net Cash from / (used in) Financing Activities | -- | 309,019 | 49,492 |
| Increase / (Decrease) in Cash & Cash Equivalents | -- | 122,901 | (7,701) |
| Cash & Cash Equivalents at beginning of period | -- | 247,523 | 252,526 |
| Effect of Foreign Exchange Rate Changes | -- | 2,118 | 2,698 |
| Others | -- | 0 | 0 |
| Cash & Cash Equivalents at end of period | -- | 372,542 | 247,523 |
| Remarks: | Real time quote last updated: 17/09/2025 17:59 |
| Real-time basic market prices of Hong Kong securities are provided by HKEx; a Designated Website authorized by the HKEx Group to provide the Service | |
| Profit / (Loss) Attributable to Shareholders (K¥) | RMB -166,393 |
| %Change | -7.764% |
| EPS / (LPS) | RMB -1.060 |
| NBV Per Share (¥) | RMB -- |